Cephalon Wins IP Suit Over Watson's Generic Fentora
A Delaware federal judge ruled on Thursday that Watson Pharmaceuticals Inc.'s proposed generic version of Fentora infringes Cephalon Inc.'s patent for the painkiller, handing Cephalon a big victory days after the...To view the full article, register now.
Already a subscriber? Click here to view full article